Mintz Advises on Larimar Therapeutics’ $69 Million Public Offering
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Leerink Partners LLC, Guggenheim Securities, LLC, Truist Securities, Inc. and William Blair & Company, L.L.C. acted as joint book-running managers for the offering.
The Mintz corporate team included William Hicks, John Rudy, Alok Choksi, Lyndon Plothow, Amanda Mei and Nicole Gaston. Joanne Hawana provided regulatory advice, Ari Feder provided tax advice, and Terri Shieh-Newton and Evelyne Guillouet provided intellectual property advice. Members of the Mintz team are based in the Boston, New York, Washington, DC, San Francisco and San Diego offices.